Life Sciences Archivi - Pagina 5 di 16

8 dicembre 2023

Electric Wheelchair, Improving the Mobility for People

Restricted mobility can be a big hindrance for the people and especially elderly. In this regard, these people might benefit from the use of e-wheelchairs in a numerous way, such as the prospect to travel more comfortably. This blog will help you to understand why choosing an e-wheelchair is much better than a conventional wheelchair.

Manual Wheelchair vs E-Wheelchair?

A wheelchair equipped with a battery, able to be recharged and a motor to for driving the wheels is an e-wheelchair, which is also called power wheelchair.

You can move simply and deprived of exertion, versus requiring to physically turn the wheels. An e-wheelchair can be an enormous addition since there are power wheelchairs for every lifestyle, whether it is needed outside or inside.

Why E- Wheelchairs are Good?

More Accessibility at Hand

Powered wheelchairs can be moved around without exerting energy by the people, which enables people to get out for further distance. The batteries can last for about 8 hours, so the people with limited mobility can easily move around here and there

For the people needing a wheelchair but can also walk short distances, an e- wheelchair lets a person to get out with less effort. A powered wheelchair can allow improved accessibility.

More Comfort than Conventional Wheelchair

Since an e-wheelchair has a battery and motor, these are usually larger in size than conventional wheelchairs. This gives more comfort, such as bigger cushions, support and steadiness. The chair can be customized for a person so that they have optimum support while travelling around.

Safe Option to Go Around Here and There

Electric wheelchairs are surely much safer than ordinary wheelchairs because they can tip over. In the case of moving about outdoors, the e-chair is much more stable when travelling over debris and bumps on pavements and other lands. An e-wheelchair is much stable with a lower center of gravity, making the movement of the chair much safer.

Fairly Easy to Operate than Conventional Wheelchairs

Power wheelchairs are just a perfect fit for indoor use for the reason that many have compact designs and they come with anti-tilt wheels allowing for easier usage in tight spaces. For the people, who are disabled or have little to no mobility a power wheelchair can make life extremely easier; users can just move about with the pulling of a lever or push of a button. The e-wheelchairs need no rocket-science to operate, which helps in making travelling long distances and outdoor use much easier.

Coming to a Conclusion

E-wheelchairs can make life much easier for the people with limited or no movement. Before making a decision about an electric wheelchair, you should read all the benefits, it has over its conventional counterparts.

The increasing number of elderly patients all over the world, and the increasing healthcare infra, both the factors have much to do with the growing demand for wheelchairs, whether they are electric or traditional.

7 dicembre 2023

Hot Or Cold: Which Therapy Works Best?

Heat and cold treatment are commonly suggested to aid in letting go of an aching pain that results from muscle or joint harm. Basic heat treatment, or thermotherapy can include the utilization of a hot water bottle, clothes that can be heated in an oven, or a warm bath. For cold treatment or cryotherapy, a bottle filled with cold water, a pad chilled in the freezer, or cool water can be utilized. In a few cases, alternating cold and heat might aid, as it will significantly surge blood flow to the injury site.

The hot and cold therapy packs market is witnessing growth and is projected to reach USD 2,008.2 million by 2030.

Fast Facts on Cold and Heat Treatment:

Cold therapy decreases irritation by reducing blood flow. Put on within 48 hours after damage.
Heat therapy encourages blood flow and aids muscle relaxation. Usage for chronic pain.
Irregular heat and cold might aid in reducing exercise-caused muscle pain.
Never utilize extreme heat, and never put ice straight on the skin.

Cold Therapy

Cold therapy decreases blood flow to a damaged area. This decelerates the rate of inflammation and lessens the danger of swelling and tissue injury. It also deadens painful tissues, works as a local anesthetic, and reduces the pain messages being conveyed to the mind. Ice can aid in treating a swollen and inflamed joint or muscle. It is most effective within 24 hours of a wound. Rest, ice, compression, and elevation (RICE) are part of the typical treatment for sports wounds.

Heat Therapy

Applying heat to a reddened area will widen the blood vessels, help blood flow, and aid sore and tautened muscles. Enhanced circulation can support removing the buildup of lactic acid waste that happens after some kind of exercise. Heat is also psychologically comforting, which can advance its painkilling properties. Heat treatment is typically more effective than cold at treating chronic muscle pain or painful joints resulting from arthritis.

Types Of Heat Therapy

Types of heat treatment include:

Using safe heating devices in the impacted area. Numerous heat items are obtainable for online purchase, including heat wrap, electrical heating pads, hot compress, and hot water bottles.
Electronic heating pads, hot compress, hot water bottles, or heat warp.
Soaking the area in a hot bath, between 93 and 101 degrees Fahrenheit or 34 and 37.8 degrees Celsius
Utilizing heated paraffin wax treatment
Medicines like rubs or covers comprising capsicum are obtainable for purchase online.

North America Is Dominating the Market

In recent years, North America has been the largest industry for hot and cold therapy packs, and it is projected to continue to be the foremost industry during the projection period credited to the high occurrence of orthopedic illnesses, like osteoporosis and arthritis.

Hence, science has yet to resolutely find the efficiency of heat and cold treatments, but neither treatment is very strong, and the hazard of an opposing reaction, when applied to a specific point on the body, is typically low.

6 dicembre 2023

Virtual Rehabilitation Market to Observe Fastest Growth in the Homecare Settings Category

The virtual rehabilitation market will reach USD 2,312.3 million, advancing at a 24.3% compound annual growth rate, by 2030.

The progression of this industry can be mainly ascribed to the rise in the incidence of disability as well as the increase in the utilization of virtual reality for patient treatment.

Virtual reality technologies are increasingly becoming available and affordable to utilize, therefore, the attention to utilizing them for rehabilitation is on the rise. Advancements in technology have allowed the production of cost-effective and available VR systems for utilization in various settings.

In recent years, the physical rehabilitation category, based on type, accounted for the largest virtual rehabilitation market share. Because of its real-time multimodal abilities, virtual reality-based physical rehabilitation can encourage effective procedures of treatment adherence as a procedure supervised by humans. Moreover, physical rehabilitation can enhance quantitative feedback for the therapist as well as the user.

In the past few years, North America accounted for the dominating share in the virtual rehabilitation industry. The rising support from the government in the form of policies, along with the increasing activities of product outsourcing will boost the footprint of virtual reality footprint in the regional industry, in the years to come. Moreover, the North American industry is also likely to be driven by the growing infrastructure of healthcare and numerous rehabilitation care guidelines.

The European virtual rehabilitation industry is advancing at the fastest rate. This is because of the surging count of disability cases in the continent. For instance, as per the World Health Organization, there are around 135 million disabled people in the country. Moreover, as the elderly population continuously increases along with the growing incidence of injuries and non-communicable illnesses, the number of disabled people is expected to increase in the years to come.

It is because of the mounting utilization of virtual reality in the treatment of patients as well as the rising disability cases, the virtual rehabilitation industry will continue to advance in the years to come.

6 dicembre 2023

Increasing Teleconsultation Fuels Online Pharmacy Sales

The online buying of medicines is fairly common around the world in recent times. This is due to the fact that buyers are more inclined toward ordering medicines through a click rather than taking a leap to a drug store. These kinds of online websites vend prescription drugs to health- products. Most of these stores are legal outlets that protect all conventional procedures associated with drug prescription. That is the main reason most buyers are pretty much confident about ordering medicines from these online stores.

But there are a number of rogue stores that have turned up in the recent past on the internet. These deal with unlawful medications and unapproved drugs. Buyers should be conscious of these sorts of rogue stores. Everything in this world has two sides, and in that context, online pharmacy is no exception, but this certainly has more pros than cons.

This is perhaps the biggest reason for this being a trend in the contemporary world. The total sale through online pharmacies in the world will reach a value of about $261,685 million by 2030, with a healthy rate of growth of above 16%. These projections assure that the future of online pharmacies will surely be bright.

Let’s gaze at some of the advantages that these online pharmacies offer in this contemporary world, where there is an abundance of almost everything, but a sheer lack of time.

Lower prices: The first and the biggest positive of the online medical stores is that there are a hell lot of savings. Even a saving of 90% isn’t unusual when the medicines are shopped online made. Lesser drug prices, lower priced generic drugs, lower overhead costs, and lower price hikes by discount pharmacies frequently result in savings as compared to the prices of a local pharmacy. You can swiftly shop for the least prices online.

Privacy/Anonymity: One might feel more contented purchasing your medication online, or just want to speak to a medic about prescriptions and any of your health issues online rather than in person. Though, you must try to avert the use of your personal info for unauthorized purposes.

Convenience: If it seems difficult for you to physically make it to the pharmacy, live in a remote area, or have a quite busy schedule, online pharmacies allow you to sidestep travel and can save a lot of time. Numerous online pharmacies will likewise remind you when you can order a refill of medicines and supplements for maintaining your regimen.

Medical information: It is quite common for online pharmacies to provide useful info about medications and illnesses in addition to links to medical resources like universities, management agencies, and health associations.

There is a reason for the online pharmacy becoming a trend, and surging prevalence of prescriptions in hospitals, increasing access of people to online services, and last but not the least, there is an ever-increasing number of internet users all around the world.

5 dicembre 2023

Sample Preparation in NGS And Why Good Results Matter

Removing RNA or DNA particles from tissues is vital for the making of libraries. Thus, RNA or DNA removal quality is important for attaining better results in NGS. Low-quality DNA or RNA removals can be polluted with proteins or carbon-based compounds like polyphenols. And it might make library preparation difficult in numerous forms.

For example, for those libraries where polymerase chain reaction is utilized, extraction uncleanness makes intensification complex and might impact the outcomes. In other cases, impurities might decrease the effectiveness of the sequencing of target molecules.

NGS sample preparation market is witnessing growth and is projected to reach USD 5,501.2 million by 2030.

Increasing Acceptance of Next-Generation Sequencing for Hereditary Disorders

For the analysis of genetic syndromes, NGS is extensively utilized. The surging usage of next-generation sequencing in diagnostic labs has enhanced the accuracy and reliability of genetic diagnosis. Prenatal analysis and prophetic genetic testing are both using progressive genetic diagnostic methods.

The constancy and efficiency of diagnostic screening tests are becoming more important as the count of individuals going through many genetic illnesses increases. To efficiently monitor a genetic illness, quicker results with negligible faults are needed. The dependability and throughput of sample preparation for genomic sequencing will be improved with the automated NGS sample preparation.

Infectious Illnesses Are the Fastest-Rising Therapeutic Area

The next-generation sequencing aids in identifying communicable illnesses, mainly illnesses resulting from mixed contaminations, which is a severe problem. To decrease the load of infectious illnesses, the submission of several samples to labs is needed in a huge number.

Also, enhancements in next-generation sequencing tech have unlocked the prospect of emerging a complete strategy for classifying communicable pathogens.

NGS has been utilized to monitor and identify novel diseases and sicknesses that escape standard testing. The tech can continuously advance and spot each pathogen, which might exist in a sample, allowing worldwide and unbiased pathogen discovery. This has outcome in a hike in the use of NGS tools and consumables in general, involving specimen preparation.

Growing Demand for Genomics Research: There is a rising demand for genomics research, mainly in areas like modified medication, rare disease diagnostics, and cancer research. This demand is propelling the acceptance of NGS tech, such as NGS Sample Preparation, which is vital for generating high-quality sequencing information.

Expansion Into Clinical Applications: NGS tech is progressively being accepted for scientific applications, like prenatal testing, cancer diagnostics, and infectious disease testing. This gives an opportunity for businesses in the NGS sample preparation industry to advance products that are custom-made to the requirements of clinical labs and fulfill regulatory needs.

Asia-Pacific: APAC is the fastest-rising industry for NGS sample preparation, propelled by growing government steps to aid genomics research and modified medication, rising requirements for NGS tech in medical applications, and the existence of a huge patient populace. India, China, and Japan are the key industries in this region, with other Asian nations also contributing to the development of the industry.

4 dicembre 2023

Why Will Proton Therapy Rule the Particle Therapy Industry?

The global particle therapy market is experiencing growth and is projected to reach USD 1,634.4 million by 2030. This development can be attributed to the high acceptance of particle treatment for cancer treatment armed with the rise in the count of particle therapy centers throughout the globe.

In recent years, proton therapy dominated the industry with a revenue share of above 90%, and the category is also estimated to experience a higher CAGR, of around 8.5%, in the projection period. This development can be credited to the high acceptance of this treatment for treating numerous cancers, like brain tumors, pediatric cancer, and breast cancer.

According to a government agency, above 2 million females were identified with breast cancer in 2020 throughout the globe, making it the most prevalent cancer. Products, like synchrotrons, cyclotrons, and synchrocyclotrons, hold over 80% of the industry share, credited to the increasing acceptance of cyclotrons in numerous hospitals armed with numerous benefits provided by them like low prices. Furthermore, the increasing shift toward nuclear scans for analysis, and the accessibility of technically progressive diagnostic devices also propel the industry development in this category.

During the projection period, the single-room systems category is projected to experience a higher CAGR, of approximately 9%, because of the low price per treatment and lower development price of a single-room facility. For example, according to a government source, the price of a single-room facility is approximately USD 30 million, which is relatively very high in the case of a multi-room capacity that can price approximately USD 100 million.

In recent years, pediatric cancer accounted for over 25% of the particle therapy market share, and the category is estimated to witness the fastest development, growing at a CAGR of approximately 9.0%, in the projection period, credited to its high occurrence throughout the world. Particle treatment is typically utilized in the treatment of pediatric patients because of the high mitosis rate in kids, which needs treatment that straight targets the tumor with very less long-term side effects. It offers high accuracy and radiation control with nearly no exposure to normal body cells.

In recent years, the European particle therapy industry generated the highest revenue share. Moreover, the regional industry is projected to witness the highest CAGR, of approximately 9%, in the projection period, because of the increasing count of particle therapy amenities offering clinical processes in the region. For example, above 50% of the particle therapy centers exist in Europe.

This is due to the supportive government guidelines and the existence of technologically progressive solutions for illness diagnosis. Furthermore, the existence of a huge count of distribution platforms also boosts the industry development in the region.

30 novembre 2023

High Prominence of Downstream Processing Due to Reduced Operational Cost

Downstream processing can be defined as the series of operations for biological materials such as plant tissues, tissue culture fluid, and cells to derive them from a homogenous product. The rising expenditure on research & development in the biopharmaceutical sector, along with the growing prevalence of contract manufacturing organizations, and the expansion of the biotechnology sector leads to increasing adoption of downstream processing.

In 2021, the downstream processing industry generates $21.1 billion, and it is expected to capture $51.0 billion in 2030, advancing at a rate of 10.3% from 2021 to 2030. The product is initially enclosed in the biological matrix with a massive number of varying non-target molecules. Moreover, downstream processing involves multiple processes that incrementally boost the target’s purity by exploiting its chemical and physical properties, making it distinct from contaminants.

Downstream processing involves harvesting and clarification steps for separating bulk contaminants from it such as carbohydrates, particulates, and oils, after polishing and capturing, and refining the feed stream till only the target product is left.

Moreover, downstream processing for energy effectiveness constitutes multistage unit operations after upstream processes that help in the enhancement of the final product’s quality in terms of both purity and concentration.

The major objective of downstream processing, along with maximizing the recovery rate of the product, is to minimize the production cost. The cost-effective production largely relies on the product’s nature, selection of feedstocks, as well as fermentation process, along with immobilized cells fermentation, free cells, and catalyst types.

In addition, downstream processing is an integral part of the entire production process, and numerous factors affect it. Along with bioprocess, raw materials usage, and specifications of the final product relies on DSP. It includes formulation, or direct in situ use, such as polymerization. Around 50% to 90% of the total production cost is consumed by the DSP.

The selection of the DSP relies on the type of microorganism, fermentation process, product substrate, along with target application. Varying combinations of steps with varying unit operations are utilized in most cases. As it is mentioned, numerous by-products could be generated from succinic acid fermentation, possessing similar structures and properties, such as lactic acid, and malic acid, along with their selective separation that largely affects DSP costs.

Downstream processing constitutes all unit operations after fermentation to enhance the final product, ethanol’s purity. Usually, combinations of molecular sieving and distillation are used for ethanol purification.

Ethanol contains only 5% of moisture, that is dehydrated while using azeotropic distillation. The water presence improves ethanol’s molecular polarity and keeps it separate when mixed with gasoline. Entrainer, a third chemical is then added, in azeotropic distillation. In large-scale ethanol purification, molecular sieving methods are implemented, as azeotropic distillation is expensive.

In the pharmaceutical sector, downstream processing holds a greater prominence in significantly reducing the whole manufacturing process cost. Microfiltration, ultrafiltration, nanofiltration, and reverse osmosis are largely utilized for pharmaceuticals’ downstream processing due to ease of operations.

Therefore, downstream processing is essential and holds a greater prominence in the biopharmaceutical, and biotechnology sectors in significantly reducing the operational cost.

28 novembre 2023

Clinical Trials Outsourcing Industry to Observe Fastest Growth In Asia-Pacific

The clinical trials outsourcing market will touch USD 75,573.4 million, advancing at a 7.2% compound annual growth rate, by 2030.

The advancement in this industry can be ascribed to the surging requirement to enhance efficiency and lessen research and development expenses. Furthermore, the growing count of non-communicable and communicable diseases, mounting research & development activities to manufacture new medicines, and the rising pharmaceutical & biopharmaceutical sectors, are also boosting the progression of this industry.

Additionally, governments in some nations are increasing their focus on the healthcare sector, because of the mounting incidence of people with chronic illnesses, for instance, cardiovascular diseases, lung cancer, and diabetes. Moreover, non-government and government organizations are also rising their focus on the efficacy and safety of the drug.

The phase-3 category, based on phase, held the largest share of the industry, of over 36%, in the past few years. This is because of the large number of clinical trials present in the stage of phase-3 and the high failure possibility in clearing this stage, which encourage pharmaceutical businesses to partner with outsourcing partners.

The small & mid-sized companies category, based on end user, is expected to dominate the clinical trials outsourcing market in the years to come. This is because of the increasing number of contract research organizations, mainly in Asian nations such as China, Japan, and India, which provide solutions for end-to-end clinical trials, enabling resource flexibility, resource sharing, operational capabilities expansion, and cost-efficiency.

In the past few years, the cancer category, based on application, accounted for the largest share in the industry. This is primarily because of the surging incidence of cancer, which needs precise medications to prevent, reduce pain, and cure cancer.

The nervous system disorder category will observe the highest growth rate in the years to come. This is because of the surging incidence of nervous system disorders, such as migraine, tension-type headaches, traumatic brain injury, and dementias. Furthermore, the unavailability of important medications is boosting the requirement for drug development.

The North American industry accounted for the largest share in recent years. This is because of the existence of enhanced healthcare infrastructure, an increasing number of innovative drug research studies, high healthcare spending, the existence of major players, and high funding for clinical trials in the continent.

APAC will observe the fastest growth in the industry, with more than 7.5% CAGR, in the years to come. This is primarily because of the rising activities of drug research, the increasing incidence of diseases, and the advancing healthcare infrastructure in the continent.

It is because of the increasing production of new medications and the growing number of contract research organizations, the clinical trials outsourcing industry will continue to advance in the years to come.

28 novembre 2023

Biologics CDMO Secondary Packaging Industry Will Grow Fastest in Asia-Pacific

The biologics CDMO secondary packaging market will touch USD 3,622.6 million by 2030, powering at a rate of 8.7% by the end of this decade. This growth is credited to the snowballing drug production, the increasing pharma industry, and the growing prevalence of numerous diseases, such as chronic ailments, infectious ailments, and genetic diseases.

Boxes were the largest category in the industry, with about USD 1 billion revenue, in 2021, and they will continue dominations in the years as well.

Boxes are designed explicitly for the transport of biological products, such as frozen and controlled ambient biologics. They also provide the perfect balance between temperature control and payloads.

North America had the largest revenue share, more than 40%, in the biologics CDMO secondary packaging market. This is because of the increasing outsourcing of drug research and development and production activities by major biopharma players.

Numerous companies wish to team up with competent packing providers providing non-conventional packing solutions and have the vital capabilities to formulate exclusive packing designs in a time and cost-effective manner.

Instead, the APAC will have the fastest growth in the years to come. This growth has a lot to do with the increasing prevalence of chronic ailments, the growing emphasis of businesses on contract manufacturing, and key players are keenly interested in facility developments in the Asia Pacific region.

Furthermore, the growth of the European region will be moderate in nature in the years to come. This can be mainly as a result of the increasing requirement for biologic products, for instance vaccines, driving the research and development spending of the pharma companies.

Due to the increased production of drugs all over the world, the demand for biologics CDMO secondary packaging is on the rise, and this trend will continue in the years to come as well.

28 novembre 2023

Hematology Testing – Industry Growth and Future Analysis

The hematology testing market generated a value of USD 3,987.4 million in 2022, and it will touch USD 6,335.9 million, growing at a 6.0% compound annual growth rate, by 2030.

The growth of the industry is mainly because of the increasing incidence of blood-related illnesses and the growing usage of high throughput hematology analyzers as well as advancements in technology.

In 2022, the consumables category, based on product, contributed a larger revenue share, of approximately 70%, and it will also observe a higher growth rate, of approximately 7%, in the years to come. The growth in this category is primarily because of the widespread adoption of numerous reagents and test kits to perform hematology testing.

In 2022, the reagents category, among the consumables, accounted for the largest share of approximately 60%, and it will exhibit the highest growth rate of approximately 5% in the years to come. This is because of the mounting number of laboratory tests number, as a result of the growing prevalence of infectious and chronic illnesses.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hematology-testing-market

In 2022, the global hematology diagnostics industry is led by North America, with approximately USD 2 billion, owing to the advantageous patient demographic, favorable policies of reimbursement, and increasing incidence of numerous types of blood diseases in the region.

APAC will observe the highest growth rate in the industry, of approximately 8%, in the years to come, owing to the mounting number of blood camps, growing government investments, rising consciousness about blood donation, and increasing blood disorders incidence in the region.

Moreover, India and China together hold over 50% share of the APAC industry, owing to the high acceptance of flow cytometry in these nations.

Hence, with the increasing incidence of blood-related illnesses and mounting acceptance of high-throughput hematology analyzers, the hematology testing industry will continue to advance in the years to come.